Get Started

ORIC

NASD Oric Pharmaceuticals, Inc.
Oct 29, 2026 · 12:42 AM ET EOD Market Closed

$9.30 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.30, $0.03 below the day’s high of $9.33

YTD change
+13.69%
vs 20-day SMA
-23.65%
vs 200-day SMA
-16.63%

Price ranges

Previous day
$8.65 $9.24
open $8.96 close $9.00
+$0.04 (+0.45%)
Today
$8.60 $9.33
open $8.80 now $9.30
+$0.50 (+5.68%)
Past week
$8.65 $14.20
from $13.78 now $9.30
-$4.48 (-32.51%)
Past month
$8.65 $14.31
from $13.37 now $9.30
-$4.07 (-30.44%)
This year
$7.23 $14.68
from $8.18 now $9.30
+$1.12 (+13.69%)

Price & Performance

-0.35 (-3.63%) / 6M

$6.93$9.69$12.46$15.22Apr 28Jul 29Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 77.2% away from all-time highs of $40.81
  • ORIC is up 14% since the beginning of the year
  • ORIC is down 31% over the past 12 months
  • ORIC is down 30% over the past 1 month
  • 16% of all ORIC investors are betting against ORIC

ORIC reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -30.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.38
Earnings momentum +1.6% Quarterly EPS growth
Quarterly change +1.6%

Valuation

P/E ratio N/A
Enterprise value $710.7M
Beta 1.78

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$264.8M
Debt$3.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $963.9M

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $451.83 +0.87%
MRNA Moderna, Inc. $214.17 +2.98%
RVMD Revolution Medicines, Inc. $188.72 +1.34%
ROIV Roivant Sciences Ltd. $37.11 +1.56%
BNTX BioNTech SE Sponsored ADR $87.99 +1.07%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.